NL
NL · NL · NL-d780f2fec4a9
Ocrevus 300 mg concentraat voor oplossing voor infusie
ATC L04AG08
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerRoche Registration GmbH
CountryNL (NL)
ATC codeL04AG08
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/17/1231
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentraat voor oplossing voor infusie",
"route": null,
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ocrevus-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Ocrelizumab",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp119261",
"excipients": [
"AZIJNZUUR (E 260)",
"NATRIUMACETAAT 3-WATER (E 262)",
"POLYSORBAAT 20 (E 432)",
"TREHALOSE (Alpha, Alpha-) 2-WATER",
"WATER VOOR INJECTIE"
],
"substances": [
"OCRELIZUMAB"
],
"leaflet_url": null,
"authorised_at": "2018/01/08",
"procedure_number": "EMEA/H/C/004043",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/17/1231",
"additional_monitoring": "N"
}Related drugs
Other records sharing ATC code L04AG08.
Access this data programmatically
Query Ocrevus 300 mg concentraat voor oplossing voor infusie and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.